論文發表:
1991-1995
- Chou, Y.H., J. Wei, and C.I. Lin, Halothane inhibits residual fast sodium channels in human atrial muscle. Anesthesiology, 1991. 75(4): p. 716-7.
1996-2000
- Halldin, C., C. Foged, Y.H. Chou, P. Karlsson, C.G. Swahn, J. Sandell, G. Sedvall, and L. Farde, Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. J Nucl Med, 1998. 39(12): p. 2061-8.
- Gulyas, B., C. Halldin, P. Karlsson, Y.H. Chou, C.G. Swahn, P. Bonock, M. Paroczai, and L. Farde, Brain uptake and plasma metabolism of [11C]vinpocetine: a preliminary PET study in a cynomolgus monkey. J Neuroimaging, 1999. 9(4): p. 217-22.
- Chou, Y.H., P. Karlsson, C. Halldin, H. Olsson, and L. Farde, A PET study of D(1)-like dopamine receptor ligand binding during altered endogenous dopamine levels in the primate brain. Psychopharmacology (Berl), 1999. 146(2): p. 220-7.
- Helfenbein, J., J. Sandell, C. Halldin, S. Chalon, P. Emond, Y. Okubo, Y.H. Chou, Y. Frangin, L. Douziech, L. Gareau, C.G. Swahn, J.C. Besnard, L. Farde, and D. Guilloteau, PET examination of three potent cocaine derivatives as specific radioligands for the serotonin transporter. Nucl Med Biol, 1999. 26(5): p. 491-9.
- Gulyas, B., C. Halldin, P. Karlsson, Y.H. Chou, C.G. Swahn, P. Bonoczk, and L. Farde, [Cerebral uptake and metabolism of (11C) Vinpocetine in monkeys: PET studies]. Orv Hetil, 1999. 140(30): p. 1687-91.
- Farde, L., N. Ginovart, C. Halldin, Y.H. Chou, H. Olsson, and C.G. Swahn, A PET study of. Int J Neuropsychopharmacol, 2000. 3(3): p. 203-214.
- Chou, Y.H., C. Halldin, and L. Farde, Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: a PET study. Synapse, 2000. 38(2): p. 138-43.
2001-2005
- Sandell, J., C. Halldin, V.W. Pike, Y.H. Chou, K. Varnas, H. Hall, S. Marchais, B. Nowicki, H.V. Wikstrom, C.G. Swahn, and L. Farde, New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY–radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey. Nucl Med Biol, 2001. 28(2): p. 177-85.
- Sandell, J., C. Halldin, J. Sovago, Y.H. Chou, B. Gulyas, M. Yu, P. Emond, K. Nagren, D. Guilloteau, and L. Farde, PET examination of [(11)C]5-methyl-6-nitroquipazine, a radioligand for visualization of the serotonin transporter. Nucl Med Biol, 2002. 29(6): p. 651-6.
- Nyberg, S., Y.H. Chou, and C. Halldin, Saturation of striatal D(2) dopamine receptors by clozapine. Int J Neuropsychopharmacol, 2002. 5(1): p. 11-6.
- Sandell, J., C. Halldin, Y.H. Chou, C.G. Swahn, S.O. Thorberg, and L. Farde, PET-examination and metabolite evaluation in monkey of [(11)C]NAD-299, a radioligand for visualisation of the 5-HT(1A) receptor. Nucl Med Biol, 2002. 29(1): p. 39-45.
- Halldin, C., N. Erixon-Lindroth, S. Pauli, Y.H. Chou, Y. Okubo, P. Karlsson, C. Lundkvist, H. Olsson, D. Guilloteau, P. Emond, and L. Farde, [(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. Eur J Nucl Med Mol Imaging, 2003. 30(9): p. 1220-30.
- Chou, Y.H., C. Halldin, and L. Farde, Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study. Psychopharmacology (Berl), 2003. 166(3): p. 234-40.
- Huang, W.S., Y.H. Chiang, J.C. Lin, Y.H. Chou, C.Y. Cheng, and R.S. Liu, Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson’s disease patients. J Nucl Med, 2003. 44(7): p. 999-1005.
- Huang, W.S., K.H. Ma, Y.H. Chou, C.Y. Chen, R.S. Liu, and J.C. Liu, 99mTc-TRODAT-1 SPECT in healthy and 6-OHDA lesioned parkinsonian monkeys: comparison with 18F-FDOPA PET. Nucl Med Commun, 2003. 24(1): p. 77-83.
- Huang, W.S., K.H. Ma, C.Y. Cheng, C.Y. Chen, Y.K. Fu, Y.H. Chou, S.P. Wey, and J.C. Liu, Imaging serotonin transporters with 123I-ADAM brain SPECT in healthy non-human primates. Nucl Med Commun, 2004. 25(5): p. 515-9.
- Huang, S.Y., W.W. Lin, H.C. Ko, J.F. Lee, T.J. Wang, Y.H. Chou, S.J. Yin, and R.B. Lu, Possible interaction of alcohol dehydrogenase and aldehyde dehydrogenase genes with the dopamine D2 receptor gene in anxiety-depressive alcohol dependence. Alcohol Clin Exp Res, 2004. 28(3): p. 374-84.
- Chen, C.K. and Y.H. Chou, Amisulpride-associated pedal edema. Eur Psychiatry, 2004. 19(7): p. 454-5.
- Marchais-Oberwinkler, S., B. Nowicki, V.W. Pike, C. Halldin, J. Sandell, Y.H. Chou, B. Gulyas, L.T. Brennum, L. Farde, and H.V. Wikstrom, N-oxide analogs of WAY-100635: new high affinity 5-HT(1A) receptor antagonists. Bioorg Med Chem, 2005. 13(3): p. 883-93.
- Lu, R.B., H.C. Ko, J.F. Lee, W.W. Lin, S.Y. Huang, T.J. Wang, Y.S. Wu, T.E. Lu, and Y.H. Chou, No alcoholism-protection effects of ADH1B*2 allele in antisocial alcoholics among Han Chinese in Taiwan. Alcohol Clin Exp Res, 2005. 29(12): p. 2101-7.
- Yang, Y.K., Y.H. Tarn, T.Y. Wang, C.Y. Liu, Y.C. Laio, Y.H. Chou, S.M. Lee, and C.C. Chen, Pharmacoeconomic evaluation of schizophrenia in Taiwan: model comparison of long-acting risperidone versus olanzapine versus depot haloperidol based on estimated costs. Psychiatry Clin Neurosci, 2005. 59(4): p. 385-94.
2006-2010
- Chou, Y.H., C. Halldin, and L. Farde, Clozapine binds preferentially to cortical D1-like dopamine receptors in the primate brain: a PET study. Psychopharmacology (Berl), 2006. 185(1): p. 29-35.
- Yeh, C.B., C.H. Lee, Y.H. Chou, C.J. Chang, K.H. Ma, and W.S. Huang, Evaluating dopamine transporter activity with 99mTc-TRODAT-1 SPECT in drug-naive Tourette’s adults. Nucl Med Commun, 2006. 27(10): p. 779-84.
- Ku, H.L., T.P. Su, and Y.H. Chou, Ziprasidone-associated pedal edema in the treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry, 2006. 30(5): p. 963-4.
- Wang, T.S., Y.H. Chou, and I.S. Shiah, Combined treatment of olanzapine and mirtazapine in anorexia nervosa associated with major depression. Prog Neuropsychopharmacol Biol Psychiatry, 2006. 30(2): p. 306-9.
- Chou, Y.H., W.S. Huang, T.P. Su, R.B. Lu, F.J. Wan, and Y.K. Fu, Dopamine transporters and cognitive function in methamphetamine abuser after a short abstinence: A SPECT study. Eur Neuropsychopharmacol, 2007. 17(1): p. 46-52.
- Lee, S.M., Y.H. Chou, M.H. Li, F.J. Wan, and M.H. Yen, Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry, 2007. 31(5): p. 1101-7.
- Liao, Y.L., Y.N. Sun, W.Y. Guo, Y.H. Chou, J.C. Hsieh, and Y.T. Wu, A comparison between the surface-based and mutual-information-based methods for co-registering SPECT and MR images. Conf Proc IEEE Eng Med Biol Soc, 2007. 2007: p. 868-71.
- Yang, B.H., S.J. Wang, Y.H. Chou, T.P. Su, S.P. Chen, J.S. Lee, and J.C. Chen, Evaluation of reference tissue model and tissue ratio method for 5-HTT using [(123)I] ADAM tracer. Comput Methods Programs Biomed, 2008. 92(3): p. 294-8.
- Lee, S.M., Y.H. Chou, M.H. Li, F.J. Wan, and M.H. Yen, Effects of haloperidol and risperidone on cerebrohemodynamics in drug-naive schizophrenic patients. J Psychiatr Res, 2008. 42(4): p. 328-35.
- Huang, C.C., I.H. Wei, Y.H. Chou, and T.P. Su, Effect of age, gender, menopausal status, and ovarian hormonal level on rTMS in treatment-resistant depression. Psychoneuroendocrinology, 2008. 33(6): p. 821-31.
- Yang, K.C., T.P. Su, and Y.H. Chou, Effectiveness of aripiprazole in treating obsessive compulsive symptoms. Prog Neuropsychopharmacol Biol Psychiatry, 2008. 32(2): p. 585-6.
- Lin, W.C. and Y.H. Chou, Aripiprazole effects on psychosis and chorea in a patient with Huntington’s disease. Am J Psychiatry, 2008. 165(9): p. 1207-8.
- Lin, Y.R., M.H. Wu, C.I. Yang, T.H. Chen, C.C. Hsu, Y.C. Chang, W.C. Tzeng, Y.H. Chou, and K.R. Chou, Evaluation of assertiveness training for psychiatric patients. J Clin Nurs, 2008. 17(21): p. 2875-83.
- Yao, W.J., H.A. Pan, Y.K. Yang, Y.H. Chou, S.T. Wang, C.Y. Yu, and H.D. Lin, Reduced frontal perfusion in depressed postmenopausal women: a SPECT study with WCST. Maturitas, 2008. 59(1): p. 83-90.
- Chou, Y.H., B.H. Yang, M.Y. Chung, S.P. Chen, T.P. Su, C.C. Chen, and S.J. Wang, Imaging the serotonin transporter using (123)I-ADAM in the human brain. Psychiatry Res, 2009. 172(1): p. 38-43.
- Yeh, H.W., N.S. Tzeng, H. Chu, Y.H. Chou, R.B. Lu, A.P. O’Brien, Y.C. Chang, C.J. Hsieh, and K.R. Chou, The risk of eating disorders among female undergraduates in Taiwan. Arch Psychiatr Nurs, 2009. 23(6): p. 430-40.
- Chen, W.C., H. Chu, R.B. Lu, Y.H. Chou, C.H. Chen, Y.C. Chang, A.P. O’Brien, and K.R. Chou, Efficacy of progressive muscle relaxation training in reducing anxiety in patients with acute schizophrenia. J Clin Nurs, 2009. 18(15): p. 2187-96.
- Li, C.T., Y.H. Chou, and T.P. Su, Duloxetine in treating medically unexplained pain and Raynaud’s phenomenon. J Neuropsychiatry Clin Neurosci, 2009. 21(4): p. 475-6.
- Huang, K.L., T.P. Su, T.J. Chen, Y.H. Chou, and Y.M. Bai, Comorbidity of cardiovascular diseases with mood and anxiety disorder: a population based 4-year study. Psychiatry Clin Neurosci, 2009. 63(3): p. 401-9.
- Li, C.T., Y.H. Chou, K.C. Yang, C.H. Yang, Y.C. Lee, and T.P. Su, Medically unexplained symptoms and somatoform disorders: diagnostic challenges to psychiatrists. J Chin Med Assoc, 2009. 72(5): p. 251-6.
- Su, T.P., L. Zhang, M.Y. Chung, Y.S. Chen, Y.M. Bi, Y.H. Chou, J.L. Barker, J.E. Barrett, D. Maric, X.X. Li, H. Li, M.J. Webster, D. Benedek, J.R. Carlton, and R. Ursano, Levels of the potential biomarker p11 in peripheral blood cells distinguish patients with PTSD from those with other major psychiatric disorders. J Psychiatr Res, 2009. 43(13): p. 1078-85.
- Bai, Y.M., K.H. Chou, C.P. Lin, I.Y. Chen, C.T. Li, K.C. Yang, Y.H. Chou, and T.P. Su, White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study. Schizophr Res, 2009. 109(1-3): p. 167-81.
- Yao, W.J., H.A. Pan, S.T. Wang, Y.K. Yang, Y.H. Chou, and H.D. Lin, Frontal cerebral blood flow changes after hormone replacement therapy in depressed postmenopausal women. J Cereb Blood Flow Metab, 2009. 29(12): p. 1885-90.
- Chou, Y.H., S.J. Wang, C.L. Lin, W.C. Mao, S.M. Lee, and M.H. Liao, Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study. Bipolar Disord, 2010. 12(3): p. 312-8.
- Li, C.T., T.P. Su, Y.H. Chou, Y.C. Lee, M.E. Liu, H.L. Ku, I.K. Shan, and Y.M. Bai, Symptomatic resolution among Chinese patients with schizophrenia and associated factors. J Formos Med Assoc, 2010. 109(5): p. 378-88.
- Cheng, K.J., Y.H. Chou, and Y.J. Liou, Efficacy of bupropion for irritable bowel syndrome. Psychosomatics, 2010. 51(6): p. 536-7.
- Hu, L.Y. and Y.H. Chou, Manic episode precedes development of early dementia: a case report. Int Psychogeriatr, 2010. 22(5): p. 834-6.
- Ku, H.L., K.C. Yang, Y.C. Lee, M.B. Lee, and Y.H. Chou, Predictors of carbon monoxide poisoning-induced delayed neuropsychological sequelae. Gen Hosp Psychiatry, 2010. 32(3): p. 310-4.
2011-2015
- Hsu, J.W., S.J. Wang, C.L. Lin, W.C. Hsieh, J.F. Lirng, Y.C. Shen, M.H. Liao, and Y.H. Chou, Short term vs. long term test-retest reproducibility of (1)(2)(3)I-ADAM for the binding of serotonin transporters in the human brain. Psychiatry Res, 2011. 194(3): p. 224-229.
- Yang, K.C., H.L. Ku, C.L. Wu, S.J. Wang, C.C. Yang, J.F. Deng, M.B. Lee, and Y.H. Chou, Striatal dopamine transporter binding for predicting the development of delayed neuropsychological sequelae in suicide attempters by carbon monoxide poisoning: A SPECT study. Psychiatry Res, 2011. 194(3): p. 219-223.
- Wu, C.L., K.C. Yang, S.J. Wang, and Y.H. Chou, Aripiprazole can treat psychotic features but not motor symptoms of Parkinson’s disease: evidence from a SPECT study. Prog Neuropsychopharmacol Biol Psychiatry, 2011. 35(1): p. 278-9.
- Hsu, J.W., T.P. Su, C.Y. Huang, Y.S. Chen, and Y.H. Chou, Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naive first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study. J Clin Psychopharmacol, 2011. 31(5): p. 577-81.
- Zhang, L., T.P. Su, K. Choi, W. Maree, C.T. Li, M.Y. Chung, Y.S. Chen, Y.M. Bai, Y.H. Chou, J.L. Barker, J.E. Barrett, X.X. Li, H. Li, D.M. Benedek, and R. Ursano, P11 (S100A10) as a potential biomarker of psychiatric patients at risk of suicide. J Psychiatr Res, 2011. 45(4): p. 435-41.
- Chen, P.S., T.L. Yeh, I.H. Lee, C.B. Lin, H.C. Tsai, K.C. Chen, N.T. Chiu, W.J. Yao, Y.K. Yang, and Y.H. Chou, Effects of C825T polymorphism of the GNB3 gene on availability of dopamine transporter in healthy volunteers–a SPECT study. Neuroimage, 2011. 56(3): p. 1526-30.
- Lee, C.Y. and Y.H. Chou, Aripiprazole in treating a manic episode associated with hydrocephalus: a case report. Prim Care Companion CNS Disord, 2011. 13(1).
- Su, K.H., J.S. Chen, J.S. Lee, C.M. Hu, C.W. Chang, Y.H. Chou, R.S. Liu, and J.C. Chen, Image segmentation and activity estimation for microPET 11C-raclopride images using an expectation-maximum algorithm with a mixture of Poisson distributions. Comput Med Imaging Graph, 2011. 35(5): p. 417-26.
- Tsai, C.W., D. Gunnell, Y.H. Chou, C.J. Kuo, M.B. Lee, and Y.Y. Chen, Why do people choose charcoal burning as a method of suicide? An interview based study of survivors in Taiwan. J Affect Disord, 2011. 131(1-3): p. 402-7.
- Yeh, C.B., Y.H. Chou, C.Y. Cheng, M.S. Lee, J.J. Wang, C.H. Lee, C.Y. Shiue, T.P. Su, and W.S. Huang, Reproducibility of brain dopamine transporter binding with Tc-99m TRODAT-1 SPECT in healthy young men. Psychiatry Res, 2012. 201(3): p. 222-5.
- Chou, Y.H., S.J. Wang, J.F. Lirng, C.L. Lin, K.C. Yang, C.K. Chen, C.B. Yeh, and M.H. Liao, Impaired cognition in bipolar I disorder: the roles of the serotonin transporter and brain-derived neurotrophic factor. J Affect Disord, 2012. 143(1-3): p. 131-7.
- Feng, C.Y., H. Chu, C.H. Chen, Y.S. Chang, T.H. Chen, Y.H. Chou, Y.C. Chang, and K.R. Chou, The effect of cognitive behavioral group therapy for depression: a meta-analysis 2000-2010. Worldviews Evid Based Nurs, 2012. 9(1): p. 2-17.
- Liang, C.S., Y.M. Bai, Y.J. Liou, and Y.H. Chou, Acute renal failure after paliperidone overdose: a case report. J Clin Psychopharmacol, 2012. 32(1): p. 128.
- Lo, Y.C., Y.H. Chou, and H.Y. Yu, PET finding in Kleine-Levin syndrome. Sleep Med, 2012. 13(6): p. 771-2.
- Chou, Y.H., C.K. Chen, S.J. Wang, S.J. Tsai, J.F. Lirng, Y.J. Liou, C.L. Lin, K.C. Yang, M.W. Lin, W.C. Lo, M.H. Liao, and C.C. Chen, Association of brain serotonin transporter availability and brain-derived neurotrophic factor in models of serotonin transporter genotypes in healthy subjects. J Clin Psychopharmacol, 2013. 33(3): p. 432-5.
- Chou, Y.H., B.H. Yang, J.W. Hsu, S.J. Wang, C.L. Lin, K.L. Huang, A. Chien Chang, and S.M. Lee, Effects of video game playing on cerebral blood flow in young adults: a SPECT study. Psychiatry Res, 2013. 212(1): p. 65-72.
- Chou, Y.H., C.L. Lin, S.J. Wang, J.F. Lirng, K.C. Yang, A. Chien Chang, and M.H. Liao, Aggression in bipolar II disorder and its relation to the serotonin transporter. J Affect Disord, 2013. 147(1-3): p. 59-63.
- Chou, Y.H., N.M. Chiu, T.T. Yang, J. Feng, C.C. Chan, and H.K. Lee, An early improvement in depressive symptoms predicts symptomatic remission of schizophrenia treated with quetiapine: a multicenter, 4-week case-control study. Int Clin Psychopharmacol, 2013. 28(5): p. 255-60.
- Hsu, J.W., J.F. Lirng, S.J. Wang, C.L. Lin, K.C. Yang, M.H. Liao, and Y.H. Chou, Association of thalamic serotonin transporter and interleukin-10 in bipolar I disorder: a SPECT study. Bipolar Disord, 2014. 16(3): p. 241-8.
- Chou, Y.C., F.H. Chao, and Y.H. Chou, Rapid development of severe skin rash after adding valproic acid in a case of bipolar depression treated with low-dose lamotrigine. J Formos Med Assoc, 2014. 113(3): p. 195-6.
- Yang, K.C., S.J. Wang, W.C. Hsieh, J.F. Lirng, C.C. Yang, J.F. Deng, C.L. Lin, and Y.H. Chou, Longitudinal changes in the dopamine transporter and cognition in suicide attempters with charcoal burning. Psychiatry Res, 2015. 231(2): p. 160-7.
- Schaffer, A., E.T. Isometsa, L. Tondo, D.H. Moreno, M. Sinyor, L.V. Kessing, G. Turecki, A. Weizman, J.M. Azorin, K. Ha, C. Reis, F. Cassidy, T. Goldstein, Z. Rihmer, A. Beautrais, Y.H. Chou, N. Diazgranados, A.J. Levitt, C.A. Zarate, Jr., and L. Yatham, Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychiatry, 2015. 49(9): p. 785-802.
- Schaffer, A., E.T. Isometsa, J.M. Azorin, F. Cassidy, T. Goldstein, Z. Rihmer, M. Sinyor, L. Tondo, D.H. Moreno, G. Turecki, C. Reis, L.V. Kessing, K. Ha, A. Weizman, A. Beautrais, Y.H. Chou, N. Diazgranados, A.J. Levitt, C.A. Zarate, Jr., and L. Yatham, A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychiatry, 2015. 49(11): p. 1006-20.
- Schaffer, A., E.T. Isometsa, L. Tondo, H.M. D, G. Turecki, C. Reis, F. Cassidy, M. Sinyor, J.M. Azorin, L.V. Kessing, K. Ha, T. Goldstein, A. Weizman, A. Beautrais, Y.H. Chou, N. Diazgranados, A.J. Levitt, C.A. Zarate, Jr., Z. Rihmer, and L.N. Yatham, International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord, 2015. 17(1): p. 1-16.
- Wei, H.T., M.H. Chen, W.W. Wong, Y.H. Chou, Y.J. Liou, T.P. Su, T.J. Chen, and Y.M. Bai, Benzodiazepines and Z-drug use among HIV-infected patients in Taiwan: a 13-year nationwide cohort study. Biomed Res Int, 2015. 2015: p. 465726.
- Chou, Y.H., P.C. Chu, S.W. Wu, J.C. Lee, Y.H. Lee, I.W. Sun, C.L. Chang, C.L. Huang, I.C. Liu, C.F. Tsai, and Y.C. Yen, A Systemic Review and Experts’ Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder. Clin Psychopharmacol Neurosci, 2015. 13(2): p. 121-8.
2016-2020
- Chou, Y.H., J.F. Lirng, W.C. Hsieh, Y.C. Chiu, Y.A. Tu, and S.J. Wang, Neither cortisol nor brain-derived neurotrophic factor is associated with serotonin transporter in bipolar disorder. Eur Neuropsychopharmacol, 2016. 26(2): p. 280-287.
- Chou, Y.H., W.C. Hsieh, L.C. Chen, J.F. Lirng, and S.J. Wang, Association between the serotonin transporter and cytokines: Implications for the pathophysiology of bipolar disorder. J Affect Disord, 2016. 191: p. 29-35.
- Chang, C.F., R.J. Yang, S.F. Chang, Y.H. Chou, and E.W. Huang, The Effects of Quality of Life and Ability to Perform Activities of Daily Living on Mild Cognitive Impairment in Older People Living in Publicly Managed Congregate Housing. J Nurs Res, 2017. 25(3): p. 187-197.
- Wu, C.H., B.H. Yang, Y.H. Chou, S.J. Wang, and J.C. Chen, Effects of 99mTc-TRODAT-1 drug template on image quantitative analysis. PLoS One, 2018. 13(3): p. e0194503.
- Lin, M.S., C.C. Lin, C.C. Yang, S.C. Weng, S.M. Wang, C.Y. Chen, N. Huang, and Y.H. Chou, Myocardial injury was associated with neurological sequelae of acute carbon monoxide poisoning in Taiwan. J Chin Med Assoc, 2018. 81(8): p. 682-690.
- Higuchi, T., M. Iyo, J.S. Kwon, Y.H. Chou, H.K. Chen, J.Y. Chen, T.T. Chen, S.Y. Huang, J.S. Lee, Y. Saeki, H. Tanaka, T.S. Wang, B.J. Wu, T. Katoh, and J. Ishigouoka, Randomized, double-blind, placebo, and risperidone-controlled study of lurasidone in the treatment of schizophrenia: Results of an inconclusive 6-week trial. Asia Pac Psychiatry, 2019. 11(3): p. e12354.
- Shih, Y.-C., C.-C. Chou, Y.-J. Lu, Y.-H. Chou, and H.-Y. Yu, Reliability and validity of the Taiwanese version of the Neurological Disorders Depression Inventory for Epilepsy (Tw-NDDI-E). Seizure, 2020. 81: p. 53-57.
2021-
- Liu, M.-N., J.G. Pantouw, K.-C. Yang, L.-Y. Hu, Y.-J. Liou, J.-F. Lirng, and Y.-H. Chou, Sub-regional hippocampal volumes in first-episode drug-naïve major depression disorder. Neuroscience Letters, 2021. 763: p. 136178.
- Chiu, Y.-C., B.-H. Yang, K.-C. Yang, M.-N. Liu, L.-Y. Hu, Y.-J. Liou, L.-Y. Chan, and Y.-H. Chou, A study of tryptophan, kynurenine and serotonin transporter in first-episode drug-naïve major depressive disorder. Psychiatry Research: Neuroimaging, 2021. 312: p. 111296.
- Yang, K.-C., B.-H. Yang, J.-F. Lirng, M.-N. Liu, L.-Y. Hu, Y.-J. Liou, L.-A. Chan, and Y.-H. Chou, Interaction of dopamine transporter and metabolite ratios underpinning the cognitive dysfunction in patients with carbon monoxide poisoning: A combined SPECT and MRS study. Neurotoxicology, 2021. 82: p. 26-34.
- Yang, K.-C., M.-N. Liu, Y.-J. Liou, L.-Y. Hu, B.-H. Yang, and Y.-H. Chou, Interleukin-1 family and serotonin transporter in first-episode, drug-naive major depressive disorder: A pilot study. Journal of Psychiatric Research, 2021. 135: p. 174-180.
- Yang, K.-C., W.-C. Hsieh, and Y.-H. Chou, Cognitive factor structure and measurement invariance between healthy controls and patients with major depressive disorder. Journal of Psychiatric Research, 2022.
- Yang, K.-C.,Chen, Y. Y., Liu, M. N., Yang, B. H., and Y.-H. Chou, Interactions between dopamine transporter and N-methyl-d-aspartate receptor-related aminoacids on cognitive impairments in schizophrenia. Schizophrenia research, 20222;48, 263–270.
- Yang, K.-C.,M.-N. Liu, B.-H. Yang, Chou YH. Role of Dopamine Transporter in the Relationship Between Plasma Cortisol and Cognition. Psychosom Med. 2022;84(6):685-694.
- Liu, M. N., Hu, L. Y., Tsai, C. F., Hong, C. J., Chou, Y. H., Chang, C. C., … & Lau, C. I. Abnormalities of Hippocampal Subfield and Amygdalar Nuclei Volumes and Clinical Correlates in Behavioral Variant Frontotemporal Dementia with Obsessive–Compulsive Behavior—A Pilot Study. Brain Sciences, 2023, 13.11: 1582
- Yang, K. C., & Chou, Y. H. Molecular imaging findings for treatment resistant depression. Progress in Brain Research, 2023, 278: 79-116.
- Chen CW, Chou YH, Liou YJ, Yang KC, Hu LY, Hsieh WC, Liu MN. Amygdala substructure volumes and serotonin transporter in first-episode, drug- naïve major depressive disorder: A pilot study. J Psychiatr Res. 2023 Apr;160:210-216.
- Yang, K. C., Yang, B. H., Lan, C. C., Liu, M. N., & Chou, Y. H. (2024). Striatal and peripheral dopaminergic alterations related to cognitive impairment in patients with schizophrenia. Psychological Medicine, 1-11.